Corentin Richard

6PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersHaematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 13, 2026
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Sandy Chevrier, Corentin Richard, Olivier Adotévi

|Nov 14, 2024
CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia.

Pierre-Simon Bellaye, Aleksandra Georgievski, Paola Ballerini

|May 25, 2022
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects.

Romain Mary, Fanny Chalmin, Théo Accogli

|Mar 25, 2022
Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series.

Julie Niogret, Valentin Derangère, Corentin Richard

|Aug 22, 2020
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.

Aurélie Fluckiger, Romain Daillère, Mohamed Sassi

|May 27, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.

Maria Paula Roberti, Satoru Yonekura, Connie P M Duong

Pageof 1

Frequent Collaborators

5 joint publications

Romain Boidot

3 joint publications

François Ghiringhelli

3 joint publications

Laurence Zitvogel

2 joint publications

Sandy Chevrier